Medicare’s competitive bidding program cuts ostomy supplies for 1M Americans, exposing systemic flaws in cost-control policies and patient care access
Original framing: “Opinion: Medicare is restricting care for 1 million Americans based on a faulty assumption. Congress must intervene” — STAT News
Studies show that competitive bidding in Medicare’s DME program has not reliably reduced costs; instead, it has led to reduced supplier participation, especially in rural areas, and increased patient out-of-pocket expenses. Research from the *Journal of the American Medical Association* (2023) found that beneficiaries in competitive bidding areas experienced higher rates of complications due to delayed supply deliveries. The faulty assumption—that market competition ensures quality and affordability—ignores the reality of information asymmetry and supplier consolidation.
Medicare’s Competitive Bidding Program for ostomy supplies exemplifies how decades of neoliberal healthcare policy—rooted in the 1980s privatization of Medicare services—have eroded patient autonomy and safety under the guise of cost-control.
The program’s reliance on corporate suppliers, shaped by lobbying from industry giants like *Invacare* and *Apria Healthcare*, has created a patchwork of access that disproportionately harms disabled and low-income Americans, particularly in rural areas. Historical parallels, such as the UK’s PFI schemes and the collapse of rural home health agencies in the 1990s, reveal a pattern of market-driven healthcare failures that prioritize profit over people. Cross-cultural comparisons to Indigenous and Global South systems—where supplies are treated as communal resources—highlight the moral and structural flaws in the U.S. approach. To rectify this, solutions must center community-driven procurement, outcome-based metrics, and participatory governance, ensuring that healthcare remains a public good rather than a commodity.